Please login to the form below

Not currently logged in
Email:
Password:

S-A and Boehringer team up for AF campaign

Sanofi-aventis and Boehringer Ingelheim are to work with the World Heart Federation to raise awareness of atrial fibrillation
The World Heart Federation, sanofi-aventis (S-A) and Boehringer Ingelheim are to collaborate on the AF AWARE (Atrial Fibrillation Awareness And Risk Education) campaign to raise awareness of atrial fibrillation (AF) and its links to severe consequences including cardiovascular (CV) mortality, stroke and CV hospitalisations. 

The campaign aims to promote education around the risks associated with AF, as well as highlight the importance of early diagnosis and comprehensive management to maximise patient outcomes.

Johanna Ralston, CEO of the World Heart Federation, said: "The AF AWARE campaign was established to specifically address the lack of awareness and endeavours to draw attention to this serious, chronic, disease, the consequences of which can have devastating effects on patients and healthcare systems."

The World Heart Federation will lead the initiative internationally and will also work closely with the Stroke Alliance for Europe and the Atrial Fibrillation Association to deliver the programme. 

Agreements have been established with sanofi-aventis and Boehringer Ingelheim for a co-sponsorship, with both companies providing funding for the campaign.

15th February 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...
Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...